XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,527,397 | -7.3% | 44,713 | +4.5% | 0.00% | 0.0% |
| Q2 2023 | $1,647,492 | -3.0% | 42,792 | -9.9% | 0.00% | 0.0% |
| Q1 2023 | $1,699,131 | +177.5% | 47,475 | +205.7% | 0.00% | – |
| Q4 2022 | $612,268 | +46.5% | 15,528 | +34.1% | 0.00% | – |
| Q3 2022 | $418,000 | +21.9% | 11,578 | +2.7% | 0.00% | – |
| Q2 2022 | $343,000 | +3.9% | 11,273 | +4.7% | 0.00% | – |
| Q1 2022 | $330,000 | +0.6% | 10,771 | +2.5% | 0.00% | – |
| Q4 2021 | $328,000 | +218.4% | 10,513 | +55.8% | 0.00% | – |
| Q3 2021 | $103,000 | +368.2% | 6,748 | +464.2% | 0.00% | – |
| Q2 2021 | $22,000 | +4.8% | 1,196 | 0.0% | 0.00% | – |
| Q1 2021 | $21,000 | +16.7% | 1,196 | 0.0% | 0.00% | – |
| Q4 2020 | $18,000 | +38.5% | 1,196 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | -13.3% | 1,196 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | – | 1,196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 467,368 | $7,188,000 | 3.91% |
| Ghost Tree Capital, LLC | 700,000 | $10,766,000 | 2.40% |
| BVF INC/IL | 3,499,346 | $53,820,000 | 2.12% |
| DAFNA Capital Management LLC | 346,535 | $5,330,000 | 1.59% |
| Parkman Healthcare Partners LLC | 361,689 | $5,563,000 | 1.42% |
| KNOTT DAVID M | 200,000 | $3,076,000 | 1.39% |
| Soleus Capital Management, L.P. | 558,117 | $8,584,000 | 1.13% |
| Avoro Capital Advisors LLC | 2,800,000 | $43,064,000 | 0.74% |
| NEA Management Company, LLC | 992,107 | $15,259,000 | 0.40% |
| Orbimed Advisors | 2,497,917 | $38,418,000 | 0.34% |